VALEANT PHARMACEUTICALS INTL 9.25 percent 01Apr2026 is a Senior Unsecured Note issued by the corporate entity on the 12th of March 2018. Bausch is trading at 83.18 as of the 25th of March 2025, a 15.98 percent decrease since the beginning of the trading day. The bond's open price was 99.0. Bausch has about a 36 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Ratings for Bausch Health Companies are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of December 2024 and ending today, the 25th of March 2025. Click here to learn more.
Our tools can tell you how much better you can do entering a position in Bausch without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Positions Ratings Now
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bausch financial ratios help investors to determine whether Bausch Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bausch with respect to the benefits of owning Bausch security.